
Breaking the Bottleneck: Rethinking Study Start-Up for Faster Trial Activation
Study start-up remains one of the most persistent bottlenecks in clinical trials—slowing site activation, delaying patient enrollment, and adding pressure across already stretched teams. In this episode of WCG Talks Tria








